Date: September 7, 2018 Location: The Research Institute at Nationwide Children’s Hospital, Columbus, OH Registration is free! Registration: Click here to register to attend Hosts
Nationwide Children’s Hospital Division of Hematology/Oncology/BMT Nationwide Children’s Hospital Education Institute
Featured Topics
Precision Medicine/Genomics Canine Comparative Oncology Radiation Oncology Clinical Trials/New Therapeutic Developments
Keynote Speaker Abha Gupta, MD, The Hospital for Sick Children Katherine A. Janeway, MD, Dana-Farber Cancer Institute Stephen L. Lessnick, MD, PhD, Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases Lars M. Wagner, MD, University of Kentucky HealthCare Conference Agenda Click here to view the full conference agenda. Conference Directors
Bhuvana A. Setty, MD Nicholas D. Yeager, MD
The symposium is designed to address novel and emerging treatments of patients with primary metastatic and relapsed bone and soft tissue sarcoma. Despite intensive therapies and incorporation of novel agents, the therapeutic plateau has not been overcome. The aim of this symposium is to review known strategies of care for this patient population with aggressive disease and highlight recent and ongoing advances in the field of sarcoma biology, pre-clinical advances, new clinical trials and also the use of immune-oncology for treatment. Exhibiting Opportunities For exhibiting opportunities, please contact Kelly Hallberg at Kelly.Hallberg@NationwideChildrens.org.
Date: September 7, 2018 Location: The Research Institute at Nationwide Children’s Hospital, Columbus, OH Registration is free! Registration: Click here to register to attend Hosts
Nationwide Children’s Hospital Division of Hematology/Oncology/BMT Nationwide Children’s Hospital Education Institute
Featured Topics
Precision Medicine/Genomics Canine Comparative Oncology Radiation Oncology Clinical Trials/New Therapeutic Developments
Keynote Speaker Abha Gupta, MD, The Hospital for Sick Children Katherine A. Janeway, MD, Dana-Farber Cancer Institute Stephen L. Lessnick, MD, PhD, Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases Lars M. Wagner, MD, University of Kentucky HealthCare Conference Agenda Click here to view the full conference agenda. Conference Directors
Bhuvana A. Setty, MD Nicholas D. Yeager, MD
The symposium is designed to address novel and emerging treatments of patients with primary metastatic and relapsed bone and soft tissue sarcoma. Despite intensive therapies and incorporation of novel agents, the therapeutic plateau has not been overcome. The aim of this symposium is to review known strategies of care for this patient population with aggressive disease and highlight recent and ongoing advances in the field of sarcoma biology, pre-clinical advances, new clinical trials and also the use of immune-oncology for treatment. Exhibiting Opportunities For exhibiting opportunities, please contact Kelly Hallberg at Kelly.Hallberg@NationwideChildrens.org.
Date: September 7, 2018 Location: The Research Institute at Nationwide Children’s Hospital, Columbus, OH Registration is free! Registration: Click here to register to attend Hosts
Nationwide Children’s Hospital Division of Hematology/Oncology/BMT Nationwide Children’s Hospital Education Institute
Featured Topics
Precision Medicine/Genomics Canine Comparative Oncology Radiation Oncology Clinical Trials/New Therapeutic Developments
Keynote Speaker Abha Gupta, MD, The Hospital for Sick Children Katherine A. Janeway, MD, Dana-Farber Cancer Institute Stephen L. Lessnick, MD, PhD, Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases Lars M. Wagner, MD, University of Kentucky HealthCare Conference Agenda Click here to view the full conference agenda. Conference Directors
Bhuvana A. Setty, MD Nicholas D. Yeager, MD
The symposium is designed to address novel and emerging treatments of patients with primary metastatic and relapsed bone and soft tissue sarcoma. Despite intensive therapies and incorporation of novel agents, the therapeutic plateau has not been overcome. The aim of this symposium is to review known strategies of care for this patient population with aggressive disease and highlight recent and ongoing advances in the field of sarcoma biology, pre-clinical advances, new clinical trials and also the use of immune-oncology for treatment. Exhibiting Opportunities For exhibiting opportunities, please contact Kelly Hallberg at Kelly.Hallberg@NationwideChildrens.org.
Date: September 7, 2018 Location: The Research Institute at Nationwide Children’s Hospital, Columbus, OH
Registration is free! Registration: Click here to register to attend
Hosts
- Nationwide Children’s Hospital Division of Hematology/Oncology/BMT
- Nationwide Children’s Hospital Education Institute
Featured Topics
- Precision Medicine/Genomics
- Canine Comparative Oncology
- Radiation Oncology
- Clinical Trials/New Therapeutic Developments
Keynote Speaker
Abha Gupta, MD, The Hospital for Sick Children
Katherine A. Janeway, MD, Dana-Farber Cancer Institute
Stephen L. Lessnick, MD, PhD, Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases
Lars M. Wagner, MD, University of Kentucky HealthCare
Conference Agenda
Click here to view the full conference agenda.
Conference Directors
- Bhuvana A. Setty, MD
- Nicholas D. Yeager, MD
The symposium is designed to address novel and emerging treatments of patients with primary metastatic and relapsed bone and soft tissue sarcoma. Despite intensive therapies and incorporation of novel agents, the therapeutic plateau has not been overcome. The aim of this symposium is to review known strategies of care for this patient population with aggressive disease and highlight recent and ongoing advances in the field of sarcoma biology, pre-clinical advances, new clinical trials and also the use of immune-oncology for treatment.
Exhibiting Opportunities
For exhibiting opportunities, please contact Kelly Hallberg at Kelly.Hallberg@NationwideChildrens.org.
